Why Verbio Doubters Were Wrong Before An 88% Gain
If you only glanced at Verbio’s headlines over the past year, the real surprise is not that the business kept building plants and widening its product mix, but how the share price responded. Investors who held Verbio over the past year are up 88.4%, including dividends. If you were weighing a position back on 21 October 2025, with bulls and bears pulling in opposite directions, what exactly did the available information suggest you were being paid to risk?
Verbio has already moved. See which of 190 high quality undervalued stocks still trade below our estimates.
The Case For, And Against, Verbio At The Time
The shares cost €14.72 at the start of the period, and Verbio sat between two very different stories investors had to price.
On the optimistic side, the bullish narrative pointed to a Fair Value of €30.28, a price implied by assumptions about Verbio’s future, built on 12.0% revenue growth and an 11.0% profit margin helped by bio-LNG, biomethane and green hydrogen.
The bearish view anchored on a Fair Value of €9.8 and treated electrification of transport plus tighter regulation and rising feedstock costs as serious threats, even while assuming 12.2% revenue growth with profit margins only reaching 5.2%.
What The Evidence Around Verbio Actually Tested
Verbio’s commissioning of the Bitterfeld plant for bio-based speciality chemicals supported the optimistic story about widening the product set beyond fuels. Q4 2026 results showed revenue at €531.935m and net income at €41.638m, with net margin moving from a loss of 22.5% in Q4 2025 to a 7.8% gain. The evidence pointed in both directions on how durable that profitability might be.
The whole episode turned on one assumption. Investors were effectively assessing whether Verbio could turn expansion projects into positive net margin. For another company with a similar pitch, focus on whether new assets appear first in revenue and then in recurring net income, rather than only in announcements.
What Verbio's One Year Run Now Asks You To Believe
Verbio trades at €27.7 today, after an 88.4% gain over the past year, while the selected Narrative’s Fair Value sits above the current price based on its own modelling assumptions rather than any settled fact.
The Narrative hangs on Verbio converting tight greenhouse gas quota rules and record biomethane output into steadier earnings that today’s price still does not fully credit for cash generation quality.
"Key Takeaways: Bullish analysts expect Verbio to translate structurally tighter European biofuel regulation, record biomethane volumes and new bio-based specialty chemicals into higher quality earnings that are not yet fully recognised by the market. The main thing that has to go right is that Verbio continues to benefit from strong and well functioning greenhouse gas quota markets, including sustained pricing and effective monetisation of its leading biomethane and biofuel position."
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for
Go Straight To The Source
What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.
- Company 1 - 30% below our estimate - builds software-enabled peripherals that plug into AI centred workflows for work, gaming and creation.
- Company 2 - 22% below our estimate - runs a dispersed, tech enabled law platform where senior lawyers keep a higher share of fees.
- Company 3 - 33% below our estimate - raises capital for renewable and infrastructure assets that investors access through fee based vehicles.
Three companies from the same screener. Open every one of the 203 solid balance sheet companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com